Why Partner With the Biomarkers for Alzheimer’s Disease Summit?
Are you actively looking to work with pharma and biotech companies striving to radically rethink approaches to developing biomarkers for Alzheimer’s?
The inaugural Biomarkers for Alzheimer’s Disease Summit provides the first and only industry-dedicated forum focused on identifying and validating biomarkers to develop truly disease modifying therapeutics for Alzheimer’s Disease.
Senior decision makers from pharmaceutical and biotech companies pioneering this space are actively seeking partners with reliable and scientifically robust solutions to support their biomarker identification, development and validation programs.
Here’s what they told us they need:
Partnering with the Biomarkers for Alzheimers Disease Summit will ensure you capitalize on this budding market share early, cement your position as an industry leader and support the growth and excitement towards validating exploratory biomarkers for Alzheimer’s Disease.
Here’s how you can get involved:
Position yourself as a
thought leader and
educate your market
Curate and drive the
leaders of the field
with your market audience to understand their needs
Exclusive VIP Hosting
Build or cement
Have your flag in the
ground and let the onsite
community know where you are